Related Experiment Video
Updated: Dec 21, 2025

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice
Published on: May 5, 2022
Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and
Bhurint Siripanthong1, Saman Nazarian2, Daniele Muser2
1School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
Insights
COVID-19 myocarditis involves direct viral injury and immune response. Diagnosis uses clinical findings, imaging, and possibly biopsy, requiring vigilant monitoring for arrhythmias and long-term effects.
Area of Science:
- Cardiology
- Infectious Diseases
- Pathophysiology
Background:
- Myocarditis associated with human coronaviruses, including COVID-19, is recognized.
- COVID-19 myocarditis pathophysiology likely involves direct viral effects and immune-mediated cardiac damage.
Purpose of the Study:
- To outline diagnostic approaches for COVID-19 myocarditis.
- To highlight clinical findings, imaging techniques, and potential diagnostic uncertainties.
Main Methods:
- Review of clinical findings: electrocardiogram changes, cardiac biomarkers, and impaired cardiac function.
- Evaluation of imaging modalities: cardiac MRI and computed tomographic angiography with delayed myocardial imaging.
- Consideration of endomyocardial biopsy for definitive diagnosis and treatment guidance.
Main Results:
- Clinical presentation includes ECG changes, elevated cardiac biomarkers, and reduced cardiac function.
- Cardiac CT angiography can help rule out coronary artery disease and detect myocardial inflammation.
- Endomyocardial biopsy may confirm active cardiac infection and inform immunosuppression risks.
Conclusions:
- Diagnosis of COVID-19 myocarditis requires integrating prior myocarditis knowledge with current clinical and imaging data.
- Vigilance for arrhythmias and consideration of myocardial infarction in patients with cardiovascular comorbidities are crucial.
- The long-term sequelae of COVID-19 myocarditis remain largely unknown.
Abstract:
Human coronavirus-associated myocarditis is known, and a number of coronavirus disease 19 (COVID-19)-related myocarditis cases have been reported. The pathophysiology of COVID-19-related myocarditis is thought to be a combination of direct viral injury and cardiac damage due to the host's immune response. COVID-19 myocarditis diagnosis should be guided by insights from previous coronavirus and other myocarditis experience. The clinical findings include changes in electrocardiogram and cardiac biomarkers, and impaired cardiac function. When cardiac magnetic resonance imaging is not feasible, cardiac computed tomographic angiography with delayed myocardial imaging may serve to exclude significant coronary artery disease and identify myocardial inflammatory patterns. Because many COVID-19 patients have cardiovascular comorbidities, myocardial infarction should be considered. If the diagnosis remains uncertain, an endomyocardial biopsy may help identify active cardiac infection through viral genome amplification and possibly refine the treatment risks of systemic immunosuppression. Arrhythmias are not uncommon in COVID-19 patients, but the pathophysiology is still speculative. Nevertheless, clinicians should be vigilant to provide prompt monitoring and treatment. The long-term impact of COVID-19 myocarditis, including the majority of mild cases, remains unknown.
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis IV: Nursing Management
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
